DNA Methyltransferases

2′-Deoxy-5-nitrocytidine is a potent inhibitor of DNA methyltransferase, disrupting the methylation process crucial for gene expression regulation. This compound is primarily utilized in cancer research to investigate its effects on tumorigenesis and cellular differentiation. By modulating DNA methylation patterns, it provides valuable insights into epigenetic modifications and their implications in various malignancies.

HhaI Methyltransferase is a DNA methyltransferase that specifically recognizes the sequence GCGC. This enzyme catalyzes the transfer of a methyl group to cytosine residues within this recognition site, playing a critical role in the regulation of gene expression and genomic stability. It is widely utilized in epigenetic research, DNA methylation studies, and the development of methylation-sensitive tools for molecular biology applications.

MS9024 is a selective degrader of DNA methyltransferase 1 (DNMT1), facilitating its degradation in HCT116 cells through the ubiquitin-proteasome pathway, achieving a DC50 of 35 nM. In additional cell lines, such as MDA-MB-468 and H1299, MS9024 shows DC50 values of 254 nM and 101 nM, respectively. Furthermore, it exhibits inhibitory activity against DNMT1 with an IC50 of 0.43 μM, making it a valuable tool for studying the role of DNMT1 in epigenetic regulation and its implications in cancer research.

(Rac)-RG108, a potent DNMT1 inhibitor, specifically targets DNA methyltransferases, playing a crucial role in epigenetic regulation. By blocking DNMT1 activity, it can modulate DNA methylation patterns, making it a valuable tool in epigenetic research. This compound is useful for studies investigating gene expression, cancer biology, and potential therapeutic strategies for diseases related to altered DNA methylation.

DNMT1-IN-4 is a potent non-nucleoside inhibitor of DNA methyltransferase 1 (DNMT1), exhibiting an IC50 value of 2.5 µM. This compound demonstrates selective inhibition of DNMT1 over other AdoMet-dependent protein methyltransferases. DNMT1-IN-4 effectively reduces cancer cell proliferation, making it a valuable tool for investigating the role of DNA methylation in cancer biology and epigenetic research.

SC83288 is an inhibitor of PfDNMT2 in Plasmodium falciparum, with an IC50 of 7 μM. This compound disrupts the epigenetic regulation within malaria parasites, impeding DNA replication and nuclear division, and consequently arrests the development of the asexual blood stage. SC83288 also induces pyknotic morphology in the parasites without impacting cytokinesis post-nuclear division or parasite egress, making it valuable for malaria-related research applications.